Organization
Tata Memorial Centre
11 clinical trials
27 abstracts
Abstract
Phase 3 randomized study for evaluation of physician choice Rx and triple metronomic as second-line therapy in head and neck cancer (CRSF 2021-HN-001).Org: Narayana Multispeciality Hospital, Tata Memorial Hospital, Homi Bhabha cancer hospital and research centre, Regency Hospital, National Cancer Insitute,
Abstract
Use of artificial intelligence (Al) in augmenting prior authorisation process for financial support in hemato-lymphoid malignancies: Joint project of Navya Al and Indian Cancer Society Cancer Cure Fund (ICS-CCF).Org: Tata Memorial Centre, Bone Marrow Transplant Unit, Advance Centre for Treatment, Research and Education in Cancer, Indian Cancer Society,
Abstract
Retrospective analysis: Does 5-FU dose adjustment per DPYD mutation status affect toxicity?Org: SUNY Upstate Medical University, Tata Memorial Centre, Hinduja Hospital, Tata Memorial Hospital,
Abstract
SHADOW study: Comparison of conventional clinical follow-up with clinician led video follow-up in newly diagnosed patients with intermediate and high grade glioma receiving adjuvant temozolomide therapy.Org: Tata Memorial Centre, Tata Memorial Hospital, Actrec Tata Memorial Centre,
Clinical trial
Short Course Radiotherapy Based Total Neoadjuvant Therapy With Or Without Chlorophyllin (SCOTCH Study)Status: Recruiting, Estimated PCD: 2025-03-01
Abstract
Impact of hormone receptor status and tumor subtypes on clinical behavior and outcomes of breast cancer in young BRCA carriers.Org: Department of Internal Medicine and Medical Specialties (DIMI), School of Medicine, University of Genoa, Genoa, Italy, Academic Trials Promoting Team, Institut Jules Bordet, Hôpital Universitaire de Bruxelles (HUB), Brussels, Belgium, U.O. Epidemiologia Clinica, IRCCS Ospedale Policlinico San Martino, Genova, Italy, Department of Medical Oncology, Universite Paris Cité, Institut Curie, Paris, France, Division of Breast Surgery, Department of Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea,
Abstract
Clinical behavior of breast cancer in young BRCA carriers and prognostic impact of the timing of genetic testing: Results from an international cohort study.Org: IRCCS Ospedale Policlinico San Martino-University of Genova, Genoa, Italy, IRCCS Ospedale Policlinico San Martino, Genova, Italy, AOU Policlinico Paolo Giaccone, University of Palermo, Palermo, Italy, Institut Jules Bordet and Université Libre de Bruxelles (U.L.B), Brussels, Belgium, Department of Medical Oncology, Universite Paris Cité, Institut Curie, Paris, France,
Clinical trial
A Prospective, Randomized, Controlled Trial to Compare the Effect of TIVA Propofol vs Sevoflurane Anaesthetic on Serumserum Biomarkers and on PBMCs in Patients Undergoing Breast Cancer Resection SurgeryStatus: Withdrawn, Estimated PCD: 2020-10-01
Abstract
MET exon 14 skipping in NSCLC: An unMET Indian need.Org: Rajiv Gandhi Cancer Institute and Research Center, Tata Memorial Hospital, Tata Memorial Centre,
Abstract
Patient’s perception of cancer treatment outcomes in geriatric age groups: A retrospective analysis from a tertiary care centre in India.Org: Tata Memorial Hospital, Tata Memorial Centre,
Abstract
Bi-institutional spline curve analysis of lymph node mapping in gallbladder cancer operated over 12 years: Impact of location and number of lymph nodal stations.Org: Tata Memorial Hospital (HBNI), Tata Memorial Centre, Department of Medical Oncology, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) “Dino Amadori”, Meldola, Italy, Italy, Department of Surgical Oncology, Research Institute for Radiation Biology and Medicine, Hiroshima University, Hiroshima, Japan, Tata Memorial Center (HBNI),
Clinical trial
Randomized Trial to Study the Effect of Rifaximin on Gut Microbiome Diversity Post Allogeneic Stem Cell Transplant in Acute Leukemia.Status: Not yet recruiting, Estimated PCD: 2026-10-15
Clinical trial
A Prospective Phase 2 Study of Chlorophyllin for the Management of Brain Radionecrosis in Patients With Diffuse GliomaStatus: Recruiting, Estimated PCD: 2025-11-01
Clinical trial
Systemic Therapy With or Without Radiation Therapy in Unresectable Nonmetastatic Gall Bladder Carcinoma: Open Label, Parallel Arm, Phase 2/3 Integrated Randomized Clinical TrialStatus: Recruiting, Estimated PCD: 2029-07-21
Clinical trial
Phase III Randomized, Double Blind, Placebo Controlled Study of Curcumin to Reduce Mucositis in Autologous Transplant SettingStatus: Recruiting, Estimated PCD: 2025-05-16
Clinical trial
Postoperative Hypofractionated Radiation in Cervical and Endometrial Tumours: Phase II StudyStatus: Recruiting, Estimated PCD: 2026-05-25
Clinical trial
Memantine to Preserve Memory and Neurocognition Following Craniospinal Irradiation- A Randomised Controlled Trial (MEMENTO)Status: Recruiting, Estimated PCD: 2026-01-01
Clinical trial
A Study of Low Dose Bevacizumab With Conventional Radiotherapy Alone in Diffuse Intrinsic Pontine GliomaStatus: Recruiting, Estimated PCD: 2024-12-01
Clinical trial
A Pharmacokinetic-pharmacodynamic Study Assessing the Ability of Curcumin to Decrease Cytokines Involved in Mucositis in the Autologous Transplant SettingStatus: Completed, Estimated PCD: 2015-07-03
Clinical trial
Short Versus Long-term Levetiracetam in Brain Tumors: A Phase 3 Randomized Controlled Trial (LIBRA)Status: Not yet recruiting, Estimated PCD: 2031-06-01
Abstract
A randomized trial of patient navigation with symptom-monitoring in advanced lung cancer.Org: Tata Memorial Centre, Tata Memorial Hospital (HBNI), Tata Memorial Centre (HBNI), Director, Tata Memorial Centre (TMC),
Abstract
Trastuzumab (T) plus gemcitabine-cisplatin (GC) for treatment naïve HER2 positive biliary tract adenocarcinomas (BTC): A multicentre open-label, phase II study (TAB).Org: Tata Memorial Hospital (HBNI), Tata Memorial Centre, Homi Bhabha cancer hospital and research centre, Tata Memorial Center (HBNI),
Abstract
Effectiveness of NEPA, an oral fixed-dose combination of netupitant and palonosetron in the prevention of chemotherapy induce nausea (CIN): A post-hoc analysis.Org: Glenmark Pharmaceuticals Ltd, Tata Memorial Centre, Sparsh Hospital and Critical Care, Omega Hospitals, ICON TRUST,
Abstract
PD-L1 in head and neck cancers: Audit for tertiary care centre in India.Org: Tata Memorial Hospital (HBNI), Tata Memorial Centre,
Abstract
An evaluation of the financial toxicity amongst older patients with cancer in India.Org: Tata Memorial Hospital (HBNI), Tata Memorial Centre, Actrec Tata Memorial Centre, Advanced Centre for Treatment Research and Education in Cancer,
Abstract
Comparison of glomerular filtration rate estimating equations in Indian geriatric patients with cancer.Org: Actrec Tata Memorial Centre, Tata Memorial Centre, Navi Mumbai, Indiana University – Purdue University Indianapolis, Mumbai Oncocare Centre,
Abstract
Gemcitabine, cisplatin, nab-paclitaxel: The effectiveness of this regimen for gall bladder cancer.Org: Tata Memorial Hospital (HBNI), Tata Memorial Centre, Tata Memorial Center (HBNI),
Abstract
Neoadjuvant chemotherapy followed by definitive chemoradiation in technically unresectable oral cavity squamous cancers.Org: Tata Memorial Hospital (HBNI), Tata Memorial Centre,
Abstract
Retrospective analysis of Ki-67 as a predictive and prognostic marker for pathological complete response to neoadjuvant chemotherapy in breast cancer.Org: Tata Memorial Centre, BBCI (B Borooah Cancer Institute), Dr Bhubaneswar Borooah Cancer Institute,
Abstract
Liquid and tissue profiling of targetable co-mutations with KRAS in non-small cell lung cancer.Org: Fortis Cancer Institute, Rajiv Gandhi Cancer Institute and Research Centre, Tata Memorial Centre, Datar Cancer Genetics, Datar Genetics Limited,
Abstract
Dexamethasone and exercise for cancer-related fatigue: A phase III randomized controlled trial.Org: Tata Memorial Centre, Tata Memorial Hospital (HBNI), Tata Memorial Centre (HBNI),
Abstract
A comparative study evaluating the quality of life in patients receiving chemotherapy versus oral TKI in the third line and beyond setting for advanced non–small-cell lung cancer.Org: Tata Memorial Centre, Tata Memorial Hospital (HBNI),
Abstract
An audit of neoadjuvant chemotherapy in sinonasal teratocarcinosarcoma from an academic tertiary care centre in India.Org: Tata Memorial Hospital (HBNI), Tata Memorial Centre,
Abstract
Impact of pre-treatment anemia on survival in locally advanced head neck squamous cell carcinomas treated with radiation with or without concurrent chemotherapy.Org: Tata Memorial Hospital (HBNI), Tata Memorial Centre,
Abstract
Mutational profiling of true single circulating tumor cells (sCTC) in metastatic lung cancer to determine genomic heterogeneity and drug-resistance signatures.Org: OneCell Diagnostics, Cupertino, CA, OneCell Dx, Pune, Tata Memorial Hospital (HBNI),
Abstract
Vulnerability assessment and decision-making in older patients with head and neck squamous cell carcinomas planned for chemoradiation: Experience from a tertiary care cancer centre in India.Org: Tata Memorial Hospital (HBNI), Tata Memorial Centre, Tata Memorial Centre (HBNI),
Abstract
Comprehensive plasma genotyping of patients with EGFR positive NSCLC as a monitoring tool for therapy response and disease progression.Org: One Cell Dx, Tata Memorial Hospital (HBNI), OneCell Dx, Tata Memorial Centre, Indx Technology,
Abstract
Molecular technique for precise antibiotics administration in patients with cancer.Org: Tata Memorial Hospital (HBNI), Tata Memorial Centre,